Wells Fargo’s Coeptis Therapeutics Warrants COEPW Stock Holding History

Wells Fargo’s Portfolio COEPW Stock Details COEPW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1	Hold	100	–	–	﹤0.01%	7128
2025 Q4	$1	Hold	100	–	–	﹤0.01%	7051
2025 Q3	$3	Hold	100	–	–	﹤0.01%	6966
2025 Q2	$3	Hold	100	–	–	﹤0.01%	7025
2025 Q1	$1	Hold	100	–	–	﹤0.01%	6985
2024 Q4	$2	Sell	100 -100	-50%	-$2	﹤0.01%	6972
2024 Q3	$3	Buy	+200	New	+$4	﹤0.01%	6796
2024 Q1	–	Sell	-400	Closed	-$12	–	7527
2023 Q4	$12	Buy	400 +300	+300%	+$12	﹤0.01%	7340
2023 Q3	$2	Sell	100 -152,254	-100%	-$6.23K	﹤0.01%	7527
2023 Q2	$10.9K	Hold	152,354	–	–	﹤0.01%	5890
2023 Q1	$22.4K	Hold	152,354	–	–	﹤0.01%	5589
2022 Q4	$15.2K	Hold	152,354	–	–	﹤0.01%	5376
2022 Q3	$5K	Hold	152,354	–	–	﹤0.01%	5893
2022 Q2	$6K	Sell	152,354 -100	-0.1%	-$8	﹤0.01%	5937
2022 Q1	$12K	Hold	152,454	–	–	﹤0.01%	6196
2021 Q4	$49K	Hold	152,454	–	–	﹤0.01%	5969
2021 Q3	$39K	Hold	152,454	–	–	﹤0.01%	5715
2021 Q2	$82K	Hold	152,454	–	–	﹤0.01%	5372
2021 Q1	$66K	Buy	+152,454	New	+$143K	﹤0.01%	5673

Other funds holding COEPW

RCM

Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return

Meteora Capital Boca Raton, Florida $1.36B AUM 21.19% 1-Year Est. Return

SIA

SkyView Investment Advisors Shrewsbury, New Jersey $743M AUM 17.91% 1-Year Est. Return

Walleye Trading New York $60B AUM 42.19% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

HHGC

Hunting Hill Global Capital New York $129M AUM 17.34% 1-Year Est. Return

Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

Wells Fargo's COEPW Position: Q1 2026 in Review

Wells Fargo held its Coeptis Therapeutics Warrants (COEPW) position steady in Q1 2026 at 100 shares worth $1. The position accounts for ﹤0.01% of the portfolio, ranked #7128.

Wells Fargo first reported a position in COEPW in Q1 2021 and has held it in 19 quarters since. The position peaked at $82K in Q2 2021. 10 funds tracked by Wall St. Rank hold COEPW as of Q1 2026.

Wells Fargo held 100 shares of Coeptis Therapeutics Warrants worth $1 as of Q1 2026.
Wells Fargo left its Coeptis Therapeutics Warrants share count unchanged in Q1 2026.
Coeptis Therapeutics Warrants made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #7128 holding.
Wells Fargo first reported a position in Coeptis Therapeutics Warrants in Q1 2021 and has held it in 19 quarters since.
Wells Fargo's Coeptis Therapeutics Warrants position peaked at $82K in Q2 2021.
10 funds tracked by Wall St. Rank held Coeptis Therapeutics Warrants as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.